ROIV and ROIVW Related Headlines
Go Back- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
- Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List
- Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
ROIV and ROIVW Related Press Releases
Go Back- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
- Roivant Named on Fortune Media and Great Place To Work’s 2025 Best Workplaces in BioPharma List
- Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
